Industry Research Reports
Home > Reports > Service & Software > Global Cyclic Peptide Service Market Outlook, In‑Depth Analysis & Forecast to 2032
Global Cyclic Peptide Service Market Outlook, In‑Depth Analysis & Forecast to 2032
Industry: Service & Software
Published Date: 2026-03-31
Pages: 172 Pages
Report ld: 6416705
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Cyclic Peptide Service market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Cyclic peptide services refer to service organizations that provide customized synthesis, analysis and other related services of cyclic peptides. Cyclic peptides are an important class of bioactive molecules with broad application prospects, such as drug research and development, biotechnology research and other fields.
From a downstream perspective, Biopharmaceutical accounted for % of 2025 revenue, surging to US$ million by 2032 (CAGR: % from 2026–2032).
Cyclic Peptide Service leading players (including GenScript Biotech, Eurogentec, LifeTein, Biopharma PEG Scientific, AnaSpec, Scitide, JPT, CD ComputaBio, Creative Peptides, Macrocyclos, etc.), dominate supply; the top five capture approximately % of global revenue, with GenScript Biotech leading 2025 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2025 to a forecast US$ million by 2032 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2025, % share rising to % by 2032), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2032 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Cyclic Peptide Service market across value chain. It analyzes historical revenue data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players (revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middle stream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- GenScript Biotech
- Eurogentec
- LifeTein
- Biopharma PEG Scientific
- AnaSpec
- Scitide
- JPT
- CD ComputaBio
- Creative Peptides
- Macrocyclos
- Peptide Insitute
- Genepep
- Innovagen
- Bachem
- InnoPep
- Bio-Synthesis
- Biomatrik
- CPC Scientific
- Chinese Peptide
- Hangzhou All Peptide
- WuXi Discovery Services
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Cyclic Peptide Custom Synthesis Service
- Cyclic Peptide Structure Analysis Services
- Cyclic Peptide Biological Activity Evaluation Services
- Others
Segment by Application
- Biopharmaceutical
- Scientific Research
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Cyclic Peptide Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape: ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down market size by Application and country, profiles key players and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional market by Application and players, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies market size by Application, and region/country, profiles top players, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures market size by Application, and country, profiles top players, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates market size by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth: details product specs, revenue, margins; top-tier players 2025 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments
Chapter 12: Value chain and ecosystem: analyses upstream, midstream, plus downstream channels
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Cyclic Peptide Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Cyclic Peptide Service Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Cyclic Peptide Custom Synthesis Service
1.2.3 Cyclic Peptide Structure Analysis Services
1.2.4 Cyclic Peptide Biological Activity Evaluation Services
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Cyclic Peptide Service Market Size by Application, 2021 vs 2025 vs 2032
1.3.2 Biopharmaceutical
1.3.3 Scientific Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Cyclic Peptide Service Revenue Estimates and Forecasts (2021-2032)
2.2 Global Cyclic Peptide Service Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competitive Landscape
3.1 Global Cyclic Peptide Service Players’ Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2021-2026)
3.1.2 Global Key Players’ Revenue Ranking (2024 vs 2025)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Players (2021 vs 2025)
3.2 Global Cyclic Peptide Service Companies Headquarters and Service Footprint
3.3 Key Player Market Share by Product Type
3.3.1 Cyclic Peptide Custom Synthesis Service: Market Share by Key Players
3.3.2 Cyclic Peptide Structure Analysis Services: Market Share by Key Players
3.3.3 Cyclic Peptide Biological Activity Evaluation Services: Market Share by Key Players
3.3.4 Others: Market Share by Key Players
3.4 Global Cyclic Peptide Service Market Concentration and Dynamics
3.4.1 Global Market Concentration
3.4.2 Market Entry and Exit Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Product Segmentation
4.1 Global Cyclic Peptide Service Market by Type
4.1.1 Global Revenue by Type (2021-2032)
4.1.2 Global Revenue-Based Market Share by Type (2021-2032)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Cyclic Peptide Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.1.2 Revenue-Based Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2021-2032)
6.2 North America Key Players’ Revenue in 2025
6.3 North America Cyclic Peptide Service Market Size by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Cyclic Peptide Service Market Size by Country
6.5.1 North America Revenue Trends by Country
6.5.2 US
6.5.3 Canada
6.5.4 Mexico
7 Europe
7.1 Europe Market Size (2021-2032)
7.2 Europe Key Players’ Revenue in 2025
7.3 Europe Cyclic Peptide Service Market Size by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Cyclic Peptide Service Market Size by Country
7.5.1 Europe Revenue Trends by Country
7.5.2 Germany
7.5.3 France
7.5.4 U.K.
7.5.5 Italy
7.5.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2021-2032)
8.2 Asia-Pacific Key Players’ Revenue in 2025
8.3 Asia-Pacific Cyclic Peptide Service Market Size by Application (2021-2032)
8.4 Asia-Pacific Growth Accelerators and Market Barriers
8.5 Asia-Pacific Cyclic Peptide Service Market Size by Region
8.5.1 Asia-Pacific Revenue Trends by Region
8.6 China
8.7 Japan
8.8 South Korea
8.9 Australia
8.10 India
8.11 Southeast Asia
8.11.1 Indonesia
8.11.2 Vietnam
8.11.3 Malaysia
8.11.4 Philippines
8.11.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2021-2032)
9.2 Central and South America Key Players’ Revenue in 2025
9.3 Central and South America Cyclic Peptide Service Market Size by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Cyclic Peptide Service Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2021-2032)
10.2 Middle East and Africa Key Players’ Revenue in 2025
10.3 Middle East and Africa Cyclic Peptide Service Market Size by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Cyclic Peptide Service Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Israel
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 GenScript Biotech
11.1.1 GenScript Biotech Corporation Information
11.1.2 GenScript Biotech Business Overview
11.1.3 GenScript Biotech Cyclic Peptide Service Product Features and Attributes
11.1.4 GenScript Biotech Cyclic Peptide Service Revenue and Gross Margin (2021-2026)
11.1.5 GenScript Biotech Cyclic Peptide Service Revenue by Product in 2025
11.1.6 GenScript Biotech Cyclic Peptide Service Revenue by Application in 2025
11.1.7 GenScript Biotech Cyclic Peptide Service Revenue by Geographic Area in 2025
11.1.8 GenScript Biotech Cyclic Peptide Service SWOT Analysis
11.1.9 GenScript Biotech Recent Developments
11.2 Eurogentec
11.2.1 Eurogentec Corporation Information
11.2.2 Eurogentec Business Overview
11.2.3 Eurogentec Cyclic Peptide Service Product Features and Attributes
11.2.4 Eurogentec Cyclic Peptide Service Revenue and Gross Margin (2021-2026)
11.2.5 Eurogentec Cyclic Peptide Service Revenue by Product in 2025
11.2.6 Eurogentec Cyclic Peptide Service Revenue by Application in 2025
11.2.7 Eurogentec Cyclic Peptide Service Revenue by Geographic Area in 2025
11.2.8 Eurogentec Cyclic Peptide Service SWOT Analysis
11.2.9 Eurogentec Recent Developments
11.3 LifeTein
11.3.1 LifeTein Corporation Information
11.3.2 LifeTein Business Overview
11.3.3 LifeTein Cyclic Peptide Service Product Features and Attributes
11.3.4 LifeTein Cyclic Peptide Service Revenue and Gross Margin (2021-2026)
11.3.5 LifeTein Cyclic Peptide Service Revenue by Product in 2025
11.3.6 LifeTein Cyclic Peptide Service Revenue by Application in 2025
11.3.7 LifeTein Cyclic Peptide Service Revenue by Geographic Area in 2025
11.3.8 LifeTein Cyclic Peptide Service SWOT Analysis
11.3.9 LifeTein Recent Developments
11.4 Biopharma PEG Scientific
11.4.1 Biopharma PEG Scientific Corporation Information
11.4.2 Biopharma PEG Scientific Business Overview
11.4.3 Biopharma PEG Scientific Cyclic Peptide Service Product Features and Attributes
11.4.4 Biopharma PEG Scientific Cyclic Peptide Service Revenue and Gross Margin (2021-2026)
11.4.5 Biopharma PEG Scientific Cyclic Peptide Service Revenue by Product in 2025
11.4.6 Biopharma PEG Scientific Cyclic Peptide Service Revenue by Application in 2025
11.4.7 Biopharma PEG Scientific Cyclic Peptide Service Revenue by Geographic Area in 2025
11.4.8 Biopharma PEG Scientific Cyclic Peptide Service SWOT Analysis
11.4.9 Biopharma PEG Scientific Recent Developments
11.5 AnaSpec
11.5.1 AnaSpec Corporation Information
11.5.2 AnaSpec Business Overview
11.5.3 AnaSpec Cyclic Peptide Service Product Features and Attributes
11.5.4 AnaSpec Cyclic Peptide Service Revenue and Gross Margin (2021-2026)
11.5.5 AnaSpec Cyclic Peptide Service Revenue by Product in 2025
11.5.6 AnaSpec Cyclic Peptide Service Revenue by Application in 2025
11.5.7 AnaSpec Cyclic Peptide Service Revenue by Geographic Area in 2025
11.5.8 AnaSpec Cyclic Peptide Service SWOT Analysis
11.5.9 AnaSpec Recent Developments
11.6 Scitide
11.6.1 Scitide Corporation Information
11.6.2 Scitide Business Overview
11.6.3 Scitide Cyclic Peptide Service Product Features and Attributes
11.6.4 Scitide Cyclic Peptide Service Revenue and Gross Margin (2021-2026)
11.6.5 Scitide Recent Developments
11.7 JPT
11.7.1 JPT Corporation Information
11.7.2 JPT Business Overview
11.7.3 JPT Cyclic Peptide Service Product Features and Attributes
11.7.4 JPT Cyclic Peptide Service Revenue and Gross Margin (2021-2026)
11.7.5 JPT Recent Developments
11.8 CD ComputaBio
11.8.1 CD ComputaBio Corporation Information
11.8.2 CD ComputaBio Business Overview
11.8.3 CD ComputaBio Cyclic Peptide Service Product Features and Attributes
11.8.4 CD ComputaBio Cyclic Peptide Service Revenue and Gross Margin (2021-2026)
11.8.5 CD ComputaBio Recent Developments
11.9 Creative Peptides
11.9.1 Creative Peptides Corporation Information
11.9.2 Creative Peptides Business Overview
11.9.3 Creative Peptides Cyclic Peptide Service Product Features and Attributes
11.9.4 Creative Peptides Cyclic Peptide Service Revenue and Gross Margin (2021-2026)
11.9.5 Creative Peptides Recent Developments
11.10 Macrocyclos
11.10.1 Macrocyclos Corporation Information
11.10.2 Macrocyclos Business Overview
11.10.3 Macrocyclos Cyclic Peptide Service Product Features and Attributes
11.10.4 Macrocyclos Cyclic Peptide Service Revenue and Gross Margin (2021-2026)
11.10.5 Company Ten Recent Developments
11.11 Peptide Insitute
11.11.1 Peptide Insitute Corporation Information
11.11.2 Peptide Insitute Business Overview
11.11.3 Peptide Insitute Cyclic Peptide Service Product Features and Attributes
11.11.4 Peptide Insitute Cyclic Peptide Service Revenue and Gross Margin (2021-2026)
11.11.5 Peptide Insitute Recent Developments
11.12 Genepep
11.12.1 Genepep Corporation Information
11.12.2 Genepep Business Overview
11.12.3 Genepep Cyclic Peptide Service Product Features and Attributes
11.12.4 Genepep Cyclic Peptide Service Revenue and Gross Margin (2021-2026)
11.12.5 Genepep Recent Developments
11.13 Innovagen
11.13.1 Innovagen Corporation Information
11.13.2 Innovagen Business Overview
11.13.3 Innovagen Cyclic Peptide Service Product Features and Attributes
11.13.4 Innovagen Cyclic Peptide Service Revenue and Gross Margin (2021-2026)
11.13.5 Innovagen Recent Developments
11.14 Bachem
11.14.1 Bachem Corporation Information
11.14.2 Bachem Business Overview
11.14.3 Bachem Cyclic Peptide Service Product Features and Attributes
11.14.4 Bachem Cyclic Peptide Service Revenue and Gross Margin (2021-2026)
11.14.5 Bachem Recent Developments
11.15 InnoPep
11.15.1 InnoPep Corporation Information
11.15.2 InnoPep Business Overview
11.15.3 InnoPep Cyclic Peptide Service Product Features and Attributes
11.15.4 InnoPep Cyclic Peptide Service Revenue and Gross Margin (2021-2026)
11.15.5 InnoPep Recent Developments
11.16 Bio-Synthesis
11.16.1 Bio-Synthesis Corporation Information
11.16.2 Bio-Synthesis Business Overview
11.16.3 Bio-Synthesis Cyclic Peptide Service Product Features and Attributes
11.16.4 Bio-Synthesis Cyclic Peptide Service Revenue and Gross Margin (2021-2026)
11.16.5 Bio-Synthesis Recent Developments
11.17 Biomatrik
11.17.1 Biomatrik Corporation Information
11.17.2 Biomatrik Business Overview
11.17.3 Biomatrik Cyclic Peptide Service Product Features and Attributes
11.17.4 Biomatrik Cyclic Peptide Service Revenue and Gross Margin (2021-2026)
11.17.5 Biomatrik Recent Developments
11.18 CPC Scientific
11.18.1 CPC Scientific Corporation Information
11.18.2 CPC Scientific Business Overview
11.18.3 CPC Scientific Cyclic Peptide Service Product Features and Attributes
11.18.4 CPC Scientific Cyclic Peptide Service Revenue and Gross Margin (2021-2026)
11.18.5 CPC Scientific Recent Developments
11.19 Chinese Peptide
11.19.1 Chinese Peptide Corporation Information
11.19.2 Chinese Peptide Business Overview
11.19.3 Chinese Peptide Cyclic Peptide Service Product Features and Attributes
11.19.4 Chinese Peptide Cyclic Peptide Service Revenue and Gross Margin (2021-2026)
11.19.5 Chinese Peptide Recent Developments
11.20 Hangzhou All Peptide
11.20.1 Hangzhou All Peptide Corporation Information
11.20.2 Hangzhou All Peptide Business Overview
11.20.3 Hangzhou All Peptide Cyclic Peptide Service Product Features and Attributes
11.20.4 Hangzhou All Peptide Cyclic Peptide Service Revenue and Gross Margin (2021-2026)
11.20.5 Hangzhou All Peptide Recent Developments
11.21 WuXi Discovery Services
11.21.1 WuXi Discovery Services Corporation Information
11.21.2 WuXi Discovery Services Business Overview
11.21.3 WuXi Discovery Services Cyclic Peptide Service Product Features and Attributes
11.21.4 WuXi Discovery Services Cyclic Peptide Service Revenue and Gross Margin (2021-2026)
11.21.5 WuXi Discovery Services Recent Developments
12 Cyclic Peptide Service Value Chain and Ecosystem Analysis
12.1 Cyclic Peptide Service Value Chain (Ecosystem Structure)
12.2 Upstream Analysis
12.2.1 Key Technologies, Platforms and Infrastructure
12.3 Midstream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Cyclic Peptide Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Cyclic Peptide Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Cyclic Peptide Service Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Cyclic Peptide Service Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Cyclic Peptide Service Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Cyclic Peptide Service Revenue by Region (US$ Million), 2021-2026
Table 5. Global Cyclic Peptide Service Revenue by Region (US$ Million), 2027-2032
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 7. Global Cyclic Peptide Service Revenue by Players (US$ Million), 2021-2026
Table 8. Global Cyclic Peptide Service Revenue-Based Market Share by Players (2021-2026)
Table 9. Global Key Players’Ranking Shift (2024 vs 2025) (Based on Revenue)
Table 10. Global Companies by Tier (Tier 1, Tier 2, and Tier 3), based on Cyclic Peptide Service Revenue, 2025
Table 11. Global Cyclic Peptide Service Average Gross Margin (%) by Player (2021 vs 2025)
Table 12. Global Cyclic Peptide Service Companies Headquarters
Table 13. Global Cyclic Peptide Service Market Concentration Ratio (CR5)
Table 14. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Cyclic Peptide Service Revenue by Type (US$ Million), 2021-2026
Table 17. Global Cyclic Peptide Service Revenue by Type (US$ Million), 2027-2032
Table 18. Key Product Attributes and Differentiation
Table 19. Global Cyclic Peptide Service Revenue by Application (US$ Million), 2021-2026
Table 20. Global Cyclic Peptide Service Revenue by Application (US$ Million), 2027-2032
Table 21. Cyclic Peptide Service High-Growth Sectors Demand CAGR (2026-2032)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Cyclic Peptide Service Growth Accelerators and Market Barriers
Table 25. North America Cyclic Peptide Service Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 26. Europe Cyclic Peptide Service Growth Accelerators and Market Barriers
Table 27. Europe Cyclic Peptide Service Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. Asia-Pacific Cyclic Peptide Service Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Cyclic Peptide Service Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 30. Central and South America Cyclic Peptide Service Investment Opportunities and Key Challenges
Table 31. Central and South America Cyclic Peptide Service Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 32. Middle East and Africa Cyclic Peptide Service Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Cyclic Peptide Service Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 34. GenScript Biotech Corporation Information
Table 35. GenScript Biotech Description and Major Businesses
Table 36. GenScript Biotech Product Features and Attributes
Table 37. GenScript Biotech Revenue (US$ Million) and Gross Margin (2021-2026)
Table 38. GenScript Biotech Revenue Proportion by Product in 2025
Table 39. GenScript Biotech Revenue Proportion by Application in 2025
Table 40. GenScript Biotech Revenue Proportion by Geographic Area in 2025
Table 41. GenScript Biotech Cyclic Peptide Service SWOT Analysis
Table 42. GenScript Biotech Recent Developments
Table 43. Eurogentec Corporation Information
Table 44. Eurogentec Description and Major Businesses
Table 45. Eurogentec Product Features and Attributes
Table 46. Eurogentec Revenue (US$ Million) and Gross Margin (2021-2026)
Table 47. Eurogentec Revenue Proportion by Product in 2025
Table 48. Eurogentec Revenue Proportion by Application in 2025
Table 49. Eurogentec Revenue Proportion by Geographic Area in 2025
Table 50. Eurogentec Cyclic Peptide Service SWOT Analysis
Table 51. Eurogentec Recent Developments
Table 52. LifeTein Corporation Information
Table 53. LifeTein Description and Major Businesses
Table 54. LifeTein Product Features and Attributes
Table 55. LifeTein Revenue (US$ Million) and Gross Margin (2021-2026)
Table 56. LifeTein Revenue Proportion by Product in 2025
Table 57. LifeTein Revenue Proportion by Application in 2025
Table 58. LifeTein Revenue Proportion by Geographic Area in 2025
Table 59. LifeTein Cyclic Peptide Service SWOT Analysis
Table 60. LifeTein Recent Developments
Table 61. Biopharma PEG Scientific Corporation Information
Table 62. Biopharma PEG Scientific Description and Major Businesses
Table 63. Biopharma PEG Scientific Product Features and Attributes
Table 64. Biopharma PEG Scientific Revenue (US$ Million) and Gross Margin (2021-2026)
Table 65. Biopharma PEG Scientific Revenue Proportion by Product in 2025
Table 66. Biopharma PEG Scientific Revenue Proportion by Application in 2025
Table 67. Biopharma PEG Scientific Revenue Proportion by Geographic Area in 2025
Table 68. Biopharma PEG Scientific Cyclic Peptide Service SWOT Analysis
Table 69. Biopharma PEG Scientific Recent Developments
Table 70. AnaSpec Corporation Information
Table 71. AnaSpec Description and Major Businesses
Table 72. AnaSpec Product Features and Attributes
Table 73. AnaSpec Revenue (US$ Million) and Gross Margin (2021-2026)
Table 74. AnaSpec Revenue Proportion by Product in 2025
Table 75. AnaSpec Revenue Proportion by Application in 2025
Table 76. AnaSpec Revenue Proportion by Geographic Area in 2025
Table 77. AnaSpec Cyclic Peptide Service SWOT Analysis
Table 78. AnaSpec Recent Developments
Table 79. Scitide Corporation Information
Table 80. Scitide Description and Major Businesses
Table 81. Scitide Product Features and Attributes
Table 82. Scitide Revenue (US$ Million) and Gross Margin (2021-2026)
Table 83. Scitide Recent Developments
Table 84. JPT Corporation Information
Table 85. JPT Description and Major Businesses
Table 86. JPT Product Features and Attributes
Table 87. JPT Revenue (US$ Million) and Gross Margin (2021-2026)
Table 88. JPT Recent Developments
Table 89. CD ComputaBio Corporation Information
Table 90. CD ComputaBio Description and Major Businesses
Table 91. CD ComputaBio Product Features and Attributes
Table 92. CD ComputaBio Revenue (US$ Million) and Gross Margin (2021-2026)
Table 93. CD ComputaBio Recent Developments
Table 94. Creative Peptides Corporation Information
Table 95. Creative Peptides Description and Major Businesses
Table 96. Creative Peptides Product Features and Attributes
Table 97. Creative Peptides Revenue (US$ Million) and Gross Margin (2021-2026)
Table 98. Creative Peptides Recent Developments
Table 99. Macrocyclos Corporation Information
Table 100. Macrocyclos Description and Major Businesses
Table 101. Macrocyclos Product Features and Attributes
Table 102. Macrocyclos Revenue (US$ Million) and Gross Margin (2021-2026)
Table 103. Macrocyclos Recent Developments
Table 104. Peptide Insitute Corporation Information
Table 105. Peptide Insitute Description and Major Businesses
Table 106. Peptide Insitute Product Features and Attributes
Table 107. Peptide Insitute Revenue (US$ Million) and Gross Margin (2021-2026)
Table 108. Peptide Insitute Recent Developments
Table 109. Genepep Corporation Information
Table 110. Genepep Description and Major Businesses
Table 111. Genepep Product Features and Attributes
Table 112. Genepep Revenue (US$ Million) and Gross Margin (2021-2026)
Table 113. Genepep Recent Developments
Table 114. Innovagen Corporation Information
Table 115. Innovagen Description and Major Businesses
Table 116. Innovagen Product Features and Attributes
Table 117. Innovagen Revenue (US$ Million) and Gross Margin (2021-2026)
Table 118. Innovagen Recent Developments
Table 119. Bachem Corporation Information
Table 120. Bachem Description and Major Businesses
Table 121. Bachem Product Features and Attributes
Table 122. Bachem Revenue (US$ Million) and Gross Margin (2021-2026)
Table 123. Bachem Recent Developments
Table 124. InnoPep Corporation Information
Table 125. InnoPep Description and Major Businesses
Table 126. InnoPep Product Features and Attributes
Table 127. InnoPep Revenue (US$ Million) and Gross Margin (2021-2026)
Table 128. InnoPep Recent Developments
Table 129. Bio-Synthesis Corporation Information
Table 130. Bio-Synthesis Description and Major Businesses
Table 131. Bio-Synthesis Product Features and Attributes
Table 132. Bio-Synthesis Revenue (US$ Million) and Gross Margin (2021-2026)
Table 133. Bio-Synthesis Recent Developments
Table 134. Biomatrik Corporation Information
Table 135. Biomatrik Description and Major Businesses
Table 136. Biomatrik Product Features and Attributes
Table 137. Biomatrik Revenue (US$ Million) and Gross Margin (2021-2026)
Table 138. Biomatrik Recent Developments
Table 139. CPC Scientific Corporation Information
Table 140. CPC Scientific Description and Major Businesses
Table 141. CPC Scientific Product Features and Attributes
Table 142. CPC Scientific Revenue (US$ Million) and Gross Margin (2021-2026)
Table 143. CPC Scientific Recent Developments
Table 144. Chinese Peptide Corporation Information
Table 145. Chinese Peptide Description and Major Businesses
Table 146. Chinese Peptide Product Features and Attributes
Table 147. Chinese Peptide Revenue (US$ Million) and Gross Margin (2021-2026)
Table 148. Chinese Peptide Recent Developments
Table 149. Hangzhou All Peptide Corporation Information
Table 150. Hangzhou All Peptide Description and Major Businesses
Table 151. Hangzhou All Peptide Product Features and Attributes
Table 152. Hangzhou All Peptide Revenue (US$ Million) and Gross Margin (2021-2026)
Table 153. Hangzhou All Peptide Recent Developments
Table 154. WuXi Discovery Services Corporation Information
Table 155. WuXi Discovery Services Description and Major Businesses
Table 156. WuXi Discovery Services Product Features and Attributes
Table 157. WuXi Discovery Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 158. WuXi Discovery Services Recent Developments
Table 159. Technologies, Platforms and Infrastructure
Table 160. Distributors List
Table 161. Market Trends and Market Evolution
Table 162. Market Drivers and Opportunities
Table 163. Market Challenges, Risks, and Restraints
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cyclic Peptide Service Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 2. Cyclic Peptide Custom Synthesis Service Product Picture
Figure 3. Cyclic Peptide Structure Analysis Services Product Picture
Figure 4. Cyclic Peptide Biological Activity Evaluation Services Product Picture
Figure 5. Others Product Picture
Figure 6. Global Cyclic Peptide Service Market Size Growth Rate , 2021 vs 2025 vs 2032 (US$ Million)
Figure 7. Global Cyclic Peptide Service Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 8. Biopharmaceutical
Figure 9. Scientific Research
Figure 10. Others
Figure 11. Cyclic Peptide Service Report Years Considered
Figure 12. Global Cyclic Peptide Service Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Cyclic Peptide Service Revenue (US$ Million), 2021-2032
Figure 14. Global Cyclic Peptide Service Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 15. Global Cyclic Peptide Service Revenue-Based Market Share by Region (2021-2032)
Figure 16. Global Cyclic Peptide Service Revenue-Based Market Share Ranking (2025)
Figure 17. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 18. Cyclic Peptide Custom Synthesis Service Revenue-Based Market Share by Player in 2025
Figure 19. Cyclic Peptide Structure Analysis Services Revenue-Based Market Share by Player in 2025
Figure 20. Cyclic Peptide Biological Activity Evaluation Services Revenue-Based Market Share by Player in 2025
Figure 21. Others Revenue-Based Market Share by Player in 2025
Figure 22. Global Cyclic Peptide Service Revenue-Based Market Share by Type (2021-2032)
Figure 23. Global Cyclic Peptide Service Revenue-Based Market Share by Application (2021-2032)
Figure 24. North America Cyclic Peptide Service Revenue YoY (US$ Million), 2021-2032
Figure 25. North America Top 5 Players Cyclic Peptide Service Revenue (US$ Million) in 2025
Figure 26. North America Cyclic Peptide Service Revenue (US$ Million) by Application (2021-2032)
Figure 27. US Cyclic Peptide Service Revenue (US$ Million), 2021-2032
Figure 28. Canada Cyclic Peptide Service Revenue (US$ Million), 2021-2032
Figure 29. Mexico Cyclic Peptide Service Revenue (US$ Million), 2021-2032
Figure 30. Europe Cyclic Peptide Service Revenue YoY (US$ Million), 2021-2032
Figure 31. Europe Top 5 Players Cyclic Peptide Service Revenue (US$ Million) in 2025
Figure 32. Europe Cyclic Peptide Service Revenue (US$ Million) by Application (2021-2032)
Figure 33. Germany Cyclic Peptide Service Revenue (US$ Million), 2021-2032
Figure 34. France Cyclic Peptide Service Revenue (US$ Million), 2021-2032
Figure 35. U.K. Cyclic Peptide Service Revenue (US$ Million), 2021-2032
Figure 36. Italy Cyclic Peptide Service Revenue (US$ Million), 2021-2032
Figure 37. Russia Cyclic Peptide Service Revenue (US$ Million), 2021-2032
Figure 38. Asia-Pacific Cyclic Peptide Service Revenue YoY (US$ Million), 2021-2032
Figure 39. Asia-Pacific Top 8 Players Cyclic Peptide Service Revenue (US$ Million) in 2025
Figure 40. Asia-Pacific Cyclic Peptide Service Revenue (US$ Million) by Application (2021-2032)
Figure 41. Indonesia Cyclic Peptide Service Revenue (US$ Million), 2021-2032
Figure 42. Japan Cyclic Peptide Service Revenue (US$ Million), 2021-2032
Figure 43. South Korea Cyclic Peptide Service Revenue (US$ Million), 2021-2032
Figure 44. Australia Cyclic Peptide Service Revenue (US$ Million), 2021-2032
Figure 45. India Cyclic Peptide Service Revenue (US$ Million), 2021-2032
Figure 46. Indonesia Cyclic Peptide Service Revenue (US$ Million), 2021-2032
Figure 47. Vietnam Cyclic Peptide Service Revenue (US$ Million), 2021-2032
Figure 48. Malaysia Cyclic Peptide Service Revenue (US$ Million), 2021-2032
Figure 49. Philippines Cyclic Peptide Service Revenue (US$ Million), 2021-2032
Figure 50. Singapore Cyclic Peptide Service Revenue (US$ Million), 2021-2032
Figure 51. Central and South America Cyclic Peptide Service Revenue YoY (US$ Million), 2021-2032
Figure 52. Central and South America Top 5 Players Cyclic Peptide Service Revenue (US$ Million) in 2025
Figure 53. Central and South America Cyclic Peptide Service Revenue (US$ Million) by Application (2021-2032)
Figure 54. Brazil Cyclic Peptide Service Revenue (US$ Million), 2021-2032
Figure 55. Argentina Cyclic Peptide Service Revenue (US$ Million), 2021-2032
Figure 56. Middle East and Africa Cyclic Peptide Service Revenue YoY (US$ Million), 2021-2032
Figure 57. Middle East and Africa Top 5 Players Cyclic Peptide Service Revenue (US$ Million) in 2025
Figure 58. Middle East and Africa Cyclic Peptide Service Revenue (US$ Million) by Application (2021-2032)
Figure 59. GCC Countries Cyclic Peptide Service Revenue (US$ Million), 2021-2032
Figure 60. Israel Cyclic Peptide Service Revenue (US$ Million), 2021-2032
Figure 61. Egypt Cyclic Peptide Service Revenue (US$ Million), 2021-2032
Figure 62. South Africa Cyclic Peptide Service Revenue (US$ Million), 2021-2032
Figure 63. Cyclic Peptide Service Value Chain Mapping
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Cyclic Peptide Service market?
The top companies in the global Cyclic Peptide Service market are GenScript Biotech、Eurogentec、LifeTein.
Related Reports
Global Cyclic Peptide Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cyclic Peptide Service market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-31
Pages: 117
USD 4250.00
(Single User License)
Cyclic Peptide Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cyclic Peptide Service was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 144
USD 3950.00
(Single User License)
Global Cyclic Peptide Service Market Research Report 2026
The global Cyclic Peptide Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-16
Pages: 147
USD 2900.00
(Single User License)
Global Cyclic Peptide Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cyclic Peptide Service market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 120
USD 4250.00
(Single User License)
Global Cyclic Peptide Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cyclic Peptide Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 165
USD 4900.00
(Single User License)
Cyclic Peptide Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cyclic Peptide Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 148
USD 3950.00
(Single User License)
Global Cyclic Peptide Service Market Research Report 2025
The global market for Cyclic Peptide Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 101
USD 2900.00
(Single User License)
Global and United States Cyclic Peptide Service Market Report & Forecast 2024-2030
Cyclic peptide services refer to service organizations that provide customized synthesis, analysis and other related services of cyclic peptides. Cyclic peptides are an important class of bioactive molecules with broad application prospects, such as drug research and development, biotechnology research and other fields.
Published Date: 2024-04-03
Pages: 139
USD 4350.00
(Single User License)
Cyclic Peptide Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Cyclic peptide services refer to service organizations that provide customized synthesis, analysis and other related services of cyclic peptides. Cyclic peptides are an important class of bioactive molecules with broad application prospects, such as drug research and development, biotechnology research and other fields.
Published Date: 2024-04-03
Pages: 150
USD 3950.00
(Single User License)
Global Cyclic Peptide Service Market Research Report 2024
Cyclic peptide services refer to service organizations that provide customized synthesis, analysis and other related services of cyclic peptides. Cyclic peptides are an important class of bioactive molecules with broad application prospects, such as drug research and development, biotechnology research and other fields.
Published Date: 2024-04-03
Pages: 102
USD 2900.00
(Single User License)
Global Cyclic Peptide Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cyclic Peptide Service market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-31
Pages: 117
USD 4250.00 (Single User License)Cyclic Peptide Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cyclic Peptide Service was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 144
USD 3950.00 (Single User License)Global Cyclic Peptide Service Market Research Report 2026
The global Cyclic Peptide Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-16
Pages: 147
USD 2900.00 (Single User License)Global Cyclic Peptide Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cyclic Peptide Service market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 120
USD 4250.00 (Single User License)Global Cyclic Peptide Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cyclic Peptide Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 165
USD 4900.00 (Single User License)Cyclic Peptide Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cyclic Peptide Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 148
USD 3950.00 (Single User License)Global Cyclic Peptide Service Market Research Report 2025
The global market for Cyclic Peptide Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 101
USD 2900.00 (Single User License)Global and United States Cyclic Peptide Service Market Report & Forecast 2024-2030
Cyclic peptide services refer to service organizations that provide customized synthesis, analysis and other related services of cyclic peptides. Cyclic peptides are an important class of bioactive molecules with broad application prospects, such as drug research and development, biotechnology research and other fields.
Published: 2024-04-03
Pages: 139
USD 4350.00 (Single User License)Cyclic Peptide Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Cyclic peptide services refer to service organizations that provide customized synthesis, analysis and other related services of cyclic peptides. Cyclic peptides are an important class of bioactive molecules with broad application prospects, such as drug research and development, biotechnology research and other fields.
Published: 2024-04-03
Pages: 150
USD 3950.00 (Single User License)Global Cyclic Peptide Service Market Research Report 2024
Cyclic peptide services refer to service organizations that provide customized synthesis, analysis and other related services of cyclic peptides. Cyclic peptides are an important class of bioactive molecules with broad application prospects, such as drug research and development, biotechnology research and other fields.
Published: 2024-04-03
Pages: 102
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now